Harel Insurance Investments & Financial Services Ltd. Lowers Stock Holdings in Inspire Medical Systems, Inc. (NYSE:INSP)

Harel Insurance Investments & Financial Services Ltd. reduced its stake in Inspire Medical Systems, Inc. (NYSE:INSP) by 42.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 181 shares of the company’s stock after selling 136 shares during the quarter. Harel Insurance Investments & Financial Services Ltd.’s holdings in Inspire Medical Systems were worth $37,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Wellington Management Group LLP grew its stake in shares of Inspire Medical Systems by 72.8% in the 3rd quarter. Wellington Management Group LLP now owns 976,972 shares of the company’s stock valued at $193,870,000 after purchasing an additional 411,480 shares during the last quarter. OPTIMAS CAPITAL Ltd acquired a new stake in shares of Inspire Medical Systems in the 4th quarter valued at approximately $3,861,000. Seven Eight Capital LP acquired a new stake in shares of Inspire Medical Systems in the 3rd quarter valued at approximately $1,558,000. Charles Schwab Investment Management Inc. lifted its holdings in shares of Inspire Medical Systems by 3.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 256,222 shares of the company’s stock valued at $50,845,000 after buying an additional 7,838 shares during the period. Finally, Canada Pension Plan Investment Board lifted its holdings in shares of Inspire Medical Systems by 29.7% in the 3rd quarter. Canada Pension Plan Investment Board now owns 40,200 shares of the company’s stock valued at $7,977,000 after buying an additional 9,200 shares during the period. 94.91% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently commented on INSP shares. KeyCorp started coverage on Inspire Medical Systems in a report on Tuesday, February 6th. They issued an “overweight” rating and a $278.00 price target for the company. Truist Financial reissued a “buy” rating and issued a $280.00 price target on shares of Inspire Medical Systems in a report on Wednesday, March 20th. Stifel Nicolaus reissued a “hold” rating and issued a $210.00 price target on shares of Inspire Medical Systems in a report on Tuesday, January 2nd. Jefferies Financial Group assumed coverage on Inspire Medical Systems in a report on Friday, January 19th. They set a “buy” rating and a $245.00 price objective for the company. Finally, Morgan Stanley assumed coverage on Inspire Medical Systems in a report on Tuesday, March 19th. They set an “overweight” rating and a $250.00 price objective for the company. Four equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, Inspire Medical Systems has a consensus rating of “Moderate Buy” and a consensus price target of $271.29.

Insider Buying and Selling at Inspire Medical Systems

In other Inspire Medical Systems news, CEO Timothy P. Herbert sold 40,000 shares of the business’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $205.09, for a total transaction of $8,203,600.00. Following the completion of the sale, the chief executive officer now owns 63,658 shares of the company’s stock, valued at $13,055,619.22. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Inspire Medical Systems news, CEO Timothy P. Herbert sold 40,000 shares of the business’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $205.09, for a total transaction of $8,203,600.00. Following the completion of the sale, the chief executive officer now owns 63,658 shares of the company’s stock, valued at $13,055,619.22. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Jerry C. Griffin sold 554 shares of the business’s stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $197.81, for a total value of $109,586.74. Following the sale, the director now directly owns 10,636 shares of the company’s stock, valued at approximately $2,103,907.16. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 61,371 shares of company stock valued at $12,213,828. Company insiders own 4.10% of the company’s stock.

Inspire Medical Systems Stock Down 0.7 %

Shares of NYSE:INSP opened at $221.63 on Wednesday. Inspire Medical Systems, Inc. has a 52 week low of $123.27 and a 52 week high of $330.00. The business has a fifty day simple moving average of $201.23 and a 200-day simple moving average of $182.94.

Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings data on Tuesday, February 6th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.53. Inspire Medical Systems had a negative return on equity of 3.93% and a negative net margin of 3.39%. The business had revenue of $192.51 million during the quarter, compared to the consensus estimate of $186.75 million. During the same quarter in the previous year, the business earned $0.10 earnings per share. The business’s revenue for the quarter was up 39.6% on a year-over-year basis. On average, equities analysts forecast that Inspire Medical Systems, Inc. will post -0.35 EPS for the current fiscal year.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.